Business
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b i...
About this update from Helix Biopharma Corp.
[{"type":"text","content":"\n\n\n\nNov. 5, 2009 (Canada NewsWire Group) -- \nAURORA, Ontario, Nov. 5 /CNW/ --\n\n\n\n","length":261,"tagName":"div"}]